Gabapentin Capsule
Product Images NDC 71335-1198

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

A formula illustrating the calculation of creatinine clearance (CLCr). It shows the equation using variables: 140 minus age (years), multiplied by weight (kg), divided by 72 times serum creatinine (mg/dL), with an adjustment factor of 0.85 for female patients.*

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

A line graph comparing mean pain scores over 8 weeks between placebo and Gabapentin at 3600 mg/day. The x-axis shows weeks from baseline to 8; the y-axis shows mean pain scores from 0 to 10. The graph indicates a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin showing a greater decrease in pain scores than placebo.*

FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

Line graph depicting mean pain scores over seven weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis shows weeks from baseline to week 7, and the y-axis shows mean pain scores from 0 to 10. The graph highlights a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

A bar graph titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares the percentage of responders in two studies for placebo (PBO) and gabapentin (GBP) at different dosages. Study 1 shows 12% for placebo and 29% for GBP 3600 mg. Study 2 shows 14% for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg, with statistical significance indicated for gabapentin groups.*

FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

A scatter plot showing the percentage difference on the vertical axis versus daily dose in milligrams on the horizontal axis. The chart compares results from three studies labeled 'STUDY a', 'STUDY b', and 'STUDY c' using different colored squares (black for Study a, gray for Study b, and white for Study c) at doses of approximately 600, 900, 1200, and 1800 mg.*

FDA Label Image

Label (Lbl713351198)

Label for Gabapentin 100 mg capsule from Bryant Ranch Prepack. The label includes storage instructions to keep at room temperature (20°-25°C or 68°-77°F) and a warning that it may cause dizziness. It notes comparison to Neurontin 100 mg capsule by Alkem Laboratories Limited. The label specifies prescription use and displays a barcode and lot number 1523487. The NDC is 71335-1198.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.